Transaction in Own Shares

Summary by AI BETAClose X

RTW Biotech Opportunities Ltd announced on September 26, 2025, it repurchased 400,000 of its Ordinary Shares at $1.53 per share. Following the transaction, the company's issued Ordinary Share capital is 345,967,440, with 18,193,791 shares held in treasury, resulting in total voting rights of 327,773,649. The buyback was authorized by shareholders in June 2025, permitting repurchases up to 14.99% of Ordinary Shares. The company intends to hold the repurchased shares in treasury and has not determined a maximum consideration payable, but will not pay a premium to the net asset value.

Disclaimer*

UK 100

Latest directors dealings